Cervical Cancer Screening and Management Update
- Speaker:
- Angela Morehead, DNP, FNP, C-EFM
- Duration:
- 1 Hour 04 Minutes
- Format:
- Audio and Video
- Copyright:
-
Aug 01, 2023
- Product Code:
- POS078661
- Media Type:
- Digital Seminar
Description
Providers who care for women should be aware of the most recent changes to cervical cancer screening guidelines. It is not difficult to determine the plan for screening if the provider is aware of the management algorithm. However, if a clinician is not routinely doing women’s health care the changes can be confusing, and the module will enable the provider to be confident in their plan of care for cervical cancer screening and abnormality management. The changes can be very confusing and concerning for patients who are unaware, and this module can help the clinician to educate their patients regarding the updates.
Credit
Handouts/Brochure
| File type | File name | Number of pages | |
|---|---|---|---|
| Manual - Cervical Cancer Screening and Management Update (2 MB) | 43 Pages | Available after Purchase |
Speaker
Angela Morehead, DNP, FNP, C-EFM Related seminars and products
Angela Morehead, DNP, FNP, C-EFM, is a family nurse practitioner with over 15 years as a women’s healthcare provider. She is the research director for Avana Health and is adjunct faculty at Franklin University. She received her BSN and MSN from Middle Tennessee State University, and her DNP from Belmont University. Dr. Morehead has cared for patients in both inpatient and outpatient settings and has taught nursing students at the undergraduate and graduate level. She currently serves on the Tennessee Maternal Mortality Review Committee, the National Association for Nurse Practitioners in Women’s Health Competency Committee, and has published and presented on a variety of women’s health topics.
Speaker Disclosures:
Financial: Angela Morehead has employment relationships with Avana Health and IVX Health. She receives a speaking honorarium from Organon. Angela Morehead receives a speaking honorarium from PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.
Non-financial: Angela Morehead serves on the Tennessee Maternal Mortality review committee.
Additional Info
Access for Self-Study (Non-Interactive)Access never expires for this product.
Questions?
Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info
Objectives
- Identify the types of cell abnormalities that can occur on cervical cytology.
- Discuss the components of the Bethesda classification.
- Identify available resources to assist in determining necessity of screening based on age and screening history, and to outline an appropriate plan of care based on screening results.
Outline
Cervical cancer stats- Incidence
- Survival rates
- Age
- Medical history
- Environmental factors
- Access to care – demographic factors
- What is a pap test?
- Types of preparation
- Discussion of types of cells in the cervix
Bethesda classification, abnormality type (ASCUS, ASC-H, LSIL, HSIL, AGC)
ASCCP guidelines for screening
Clinical considerations
Management of abnormal results - algorithm
Case studies for management of abnormal results
Prevention – HPV vaccine
Commonly asked questions regarding pap test and HPV vaccine
Target Audience
- Nurses
- Nurse Practitioners
- Clinical Nurse Specialists
- Physician Assistants
Reviews
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
PESI Mobile App
Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.
Please wait ...